# Ruibijia

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ruibijia

- Industry: Medical Devices & Equipment
- Headquarters: Hangzhou, China
- Website: www.rebeccamed.com
- Total disclosed funding: $10M
- Latest round: Series A (Feb 1, 2024)
- Investors on record: 8

## About

Established in 2015 and based in Hangzhou, China. Ruibijia is a medical company that focuses on research and development of medical devices and equipment. It was recognized as the National High-tech Enterprise. The core team has more than ten years of experience in the medical electronics industry. In September 2017, Ruibijia won the championship in the big health category of the Entrepreneurship Bang Innovation China Competition. In February 2024, the company raised series A++ funding for USD 10 million.

Ruibijia is mainly engaged in medical device development, medical technology research, and development. Its products include microelectromechanical radiofrequency (MEMRF) medical devices, including micro-energy relays, and minimally invasive catheters. Products apply 3D non-silicon-based micro-nano technologies. It also provides technical consulting, clinical surgery diagnosis and treatment of integrated solutions, and other services. The service targets are users of medical institutions.

The company will use the series A++ funds for the promotion of the micro RF general product line and the registration and certification of new products in the Middle East, America, and Europe.

## Funding rounds

- Series A, Feb 1, 2024, $10M — MED-FINE Capital, Puhua Lingxian
- Series A, Feb 10, 2021 — Huadao Zezheng Investment
- Series A, Nov 5, 2020 — QF Capital
- Series A, May 11, 2018 — ZhenFund, Huagai Capital, Kunlun Fund, Puhua Capital

## Investors

- ZhenFund (https://capitalatlas.ai/funds/zhenfund) — Series A
- Huagai Capital (https://capitalatlas.ai/funds/huagai-capital) — Series A
- Kunlun Fund (https://capitalatlas.ai/funds/kunlun-fund) — Series A
- Puhua Capital (https://capitalatlas.ai/funds/puhua-capital) — Series A
- QF Capital (https://capitalatlas.ai/funds/qf-capital) — Series A
- Huadao Zezheng Investment (https://capitalatlas.ai/funds/huadao-zezheng-investment) — Series A
- MED-FINE Capital (https://capitalatlas.ai/funds/med-fine-capital) — Series A
- Puhua Lingxian — Series A